HAVCR2 and urothelial carcinoma: T cells widely expressed PD-1, while LAG3, TIM3, OX40, and 4-1BB were expressed at relatively low levels, which indicates that targeting these molecules in urothelial carcinoma may be less effective than targeting PD-1.